DE PONTI, FABRIZIO
DE PONTI, FABRIZIO
DIPARTIMENTO DI SCIENZE MEDICHE E CHIRURGICHE
Docenti di ruolo di Ia fascia
5-HT7 receptors are involved in the accommodation of the circular muscle during peristalsis in the guinea-pig ileum
2004 VICINI R.; CERVIO E.; AGAZZI A.; DE GIORGIO R.; BARBARA G.; DE PONTI F.; TONINI M.
5-HT7 Receptors Modulate Peristalsis and Accommodation in the Guinea Pig Ileum
2005 Marcello, Tonini; Riccardo, Vicini; Elisabetta, Cervio; Fabrizio, De Ponti; Roberto, De Giorgio; Giovanni, Barbara; Vincenzo, Stanghellini; Antonio, Dellabianca; Catia, Sternini
A clinical pharmacology and therapeutics teacher's guide to race-based medicine, inclusivity, and diversity
2023 Bakkum, Michiel J; Verdonk, Petra; Thomas, Elias G; van Rosse, Floor; Okorie, Michael; Papaioannidou, Paraskevi; Likic, Robert; Sanz, Emilio J; Christiaens, Thierry; Costa, João N; Dima, Lorena; de Ponti, Fabrizio; van Smeden, Jeroen; van Agtmael, Michiel A; Richir, Milan C; Tichelaar, Jelle
Abnormalities of human gallbladder muscle associated with inflammation: an in vitro study
2005 MASELLI M.A.; TRISOLINI P.; PIEPOLI A.L.; MONTANARO S.; CARUSO M.L.; D’ATTOMA B.; PEZZOLLA F.; DE PONTI F.
Academic output from EU-funded health research projects
2012 Mariam Molokhia;Fabrizio De Ponti;Elijah R Behr;Gianluca Trifirò;Miriam Sturkenboom
Addition of dipeptidyl peptidase-4 inhibitors to sulphonylureas and risk of hypoglycaemia: systematic review and meta-analysis
2016 Salvo, Francesco; Moore, Nicholas; Arnaud, Mickael; Robinson, Philip; Raschi, Emanuel; De Ponti, Fabrizio; Bégaud, Bernard; Pariente, Antoine
Adherence to chronic cardiovascular therapies: persistence over the years and dose coverage
2007 Poluzzi E.; Strahinja P.; Vaccheri A.; Vargiu A.; Silvani M.C.; Motola D.; Marchesini G.; De Ponti F.; Montanaro N.
Adherence to chronic cardiovascular therapies: persistence over the years and dose coverage.
2006 Poluzzi E; Strahinja P; Vargiu A; Silvani MC; Motola D; Vaccheri A; De Ponti F; Marchesini Reggiani G; Montanaro N.
Advancements in drug development for diarrhea-predominant irritable bowel syndrome
2018 Dothel, Giovanni; Barbaro, Maria Raffaella; Raschi, Emanuel; Barbara, Giovanni; De Ponti, Fabrizio*
Adverse cardiovascular events associated with triptans and ergotamines for treatment of migraine: Systematic review of observational studies
2015 Roberto, G; Raschi, E.; Piccinni, C.; Conti, V.; Vignatelli, L.; D'Alessandro, R.; De Ponti, F.; Poluzzi, E.
Adverse events associated with the use of direct-acting oral anticoagulants in clinical practice: beyond bleeding complications
2016 Raschi, Emanuel; Bianchin, Matteo; Ageno, Walter; De Ponti, Roberto; De Ponti, Fabrizio
Adverse Events to Food Supplements Containing Red Yeast Rice: Comparative Analysis of FAERS and CAERS Reporting Systems
2018 Raschi, Emanuel*; Girardi, Anna; Poluzzi, Elisabetta; Forcesi, Emanuele; Menniti-Ippolito, Francesca; Mazzanti, Gabriela; De Ponti, Fabrizio
Adverse events with sacubitril/valsartan in the real world: emerging signals to target preventive strategies from the FDA adverse event reporting system
2021 Milo Gatti, Ippazio Cosimo Antonazzo, Igor Diemberger, Fabrizio De Ponti, Emanuel Raschi
Adverse events with sodium-glucose co-transporter-2 inhibitors: A global analysis of international spontaneous reporting systems
2017 Raschi, E.; Parisotto, M.; Forcesi, E.; La Placa, M.; Marchesini, G.; De Ponti, F.; Poluzzi, E.
Advising Mothers on the Use of Medications during Breastfeeding : A Need for a Positive Attitude
2016 Davanzo, Riccardo; Bua, Jenny; De Cunto, Angela; Farina, Maria Luisa; De Ponti, Fabrizio; Clavenna, Antonio; Mandrella, Stefania; Sagone, Antonella; Clementi, Maurizio
Altered Serotonin Signaling and Extrinsic Sensory Neuron Activation in Irritable Bowel Syndrome
2010 C. Cremon; G. Carini; G. Dothel; V. Vasina; R. De Giorgio; V. Stanghellini; F. De Ponti; M. Tonini; D. Grundy; R. Corinaldesi; G. Barbara
Amyotrophic Lateral Sclerosis as an Adverse Drug Reaction: A Disproportionality Analysis of the Food and Drug Administration Adverse Event Reporting System
2022 Gaimari A.; Fusaroli M.; Raschi E.; Baldin E.; Vignatelli L.; Nonino F.; De Ponti F.; Mandrioli J.; Poluzzi E.
An update on the first decade of the European centralized procedure: how many innovative drugs?
2006 Motola D.; De Ponti F.; Poluzzi E.; Martini N.; Rossi P.; Silvani M.C.; Vaccheri A.; Montanaro N.
Animal models of chemically induced intestinal inflammation: Predictivity and ethical issues
2013 Giovanni Dothel; Valentina Vasina; Giovanni Barbara; Fabrizio De Ponti
Antibacterial macrolides: a drug class with a complex pharmacological profile
2004 ABU-GHARBIEH E.; VASINA V.; POLUZZI E.; DE PONTI F.
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| 5-HT7 receptors are involved in the accommodation of the circular muscle during peristalsis in the guinea-pig ileum | VICINI R.; CERVIO E.; AGAZZI A.; DE GIORGIO R.; BARBARA G.; DE PONTI F.; TONINI M. | 2004-01-01 | DIGESTIVE AND LIVER DISEASE | - | 4.02 Riassunto (Abstract) | - |
| 5-HT7 Receptors Modulate Peristalsis and Accommodation in the Guinea Pig Ileum | Marcello, Tonini; Riccardo, Vicini; Elisabetta, Cervio; Fabrizio, De Ponti; Roberto, De Giorgio; ...Giovanni, Barbara; Vincenzo, Stanghellini; Antonio, Dellabianca; Catia, Sternini | 2005-01-01 | GASTROENTEROLOGY | - | 1.01 Articolo in rivista | - |
| A clinical pharmacology and therapeutics teacher's guide to race-based medicine, inclusivity, and diversity | Bakkum, Michiel J; Verdonk, Petra; Thomas, Elias G; van Rosse, Floor; Okorie, Michael; Papaioanni...dou, Paraskevi; Likic, Robert; Sanz, Emilio J; Christiaens, Thierry; Costa, João N; Dima, Lorena; de Ponti, Fabrizio; van Smeden, Jeroen; van Agtmael, Michiel A; Richir, Milan C; Tichelaar, Jelle | 2023-01-01 | CLINICAL PHARMACOLOGY & THERAPEUTICS | - | 1.01 Articolo in rivista | Clin Pharma and Therapeutics - 2022 - Bakkum - A Clinical Pharmacology and Therapeutics Teacher s Guide to Race‐Based.pdf |
| Abnormalities of human gallbladder muscle associated with inflammation: an in vitro study | MASELLI M.A.; TRISOLINI P.; PIEPOLI A.L.; MONTANARO S.; CARUSO M.L.; D’ATTOMA B.; PEZZOLLA F.; DE... PONTI F. | 2005-01-01 | - | Minerva Medica | 4.02 Riassunto (Abstract) | - |
| Academic output from EU-funded health research projects | Mariam Molokhia;Fabrizio De Ponti;Elijah R Behr;Gianluca Trifirò;Miriam Sturkenboom | 2012-01-01 | THE LANCET | - | 1.04 Replica / breve intervento (e simili) | - |
| Addition of dipeptidyl peptidase-4 inhibitors to sulphonylureas and risk of hypoglycaemia: systematic review and meta-analysis | Salvo, Francesco; Moore, Nicholas; Arnaud, Mickael; Robinson, Philip; Raschi, Emanuel; De Ponti, ...Fabrizio; Bégaud, Bernard; Pariente, Antoine | 2016-01-01 | BMJ BRITISH MEDICAL JOURNAL | - | 1.01 Articolo in rivista | DPP4-BMJ.pdf |
| Adherence to chronic cardiovascular therapies: persistence over the years and dose coverage | Poluzzi E.; Strahinja P.; Vaccheri A.; Vargiu A.; Silvani M.C.; Motola D.; Marchesini G.; De Pont...i F.; Montanaro N. | 2007-01-01 | BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | - | 1.01 Articolo in rivista | - |
| Adherence to chronic cardiovascular therapies: persistence over the years and dose coverage. | Poluzzi E; Strahinja P; Vargiu A; Silvani MC; Motola D; Vaccheri A; De Ponti F; Marchesini Reggia...ni G; Montanaro N. | 2006-01-01 | PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | - | 4.02 Riassunto (Abstract) | - |
| Advancements in drug development for diarrhea-predominant irritable bowel syndrome | Dothel, Giovanni; Barbaro, Maria Raffaella; Raschi, Emanuel; Barbara, Giovanni; De Ponti, Fabrizio* | 2018-01-01 | EXPERT OPINION ON INVESTIGATIONAL DRUGS | - | 1.01 Articolo in rivista | - |
| Adverse cardiovascular events associated with triptans and ergotamines for treatment of migraine: Systematic review of observational studies | Roberto, G; Raschi, E.; Piccinni, C.; Conti, V.; Vignatelli, L.; D'Alessandro, R.; De Ponti, F.; ...Poluzzi, E. | 2015-01-01 | CEPHALALGIA | - | 1.01 Articolo in rivista | - |
| Adverse events associated with the use of direct-acting oral anticoagulants in clinical practice: beyond bleeding complications | Raschi, Emanuel; Bianchin, Matteo; Ageno, Walter; De Ponti, Roberto; De Ponti, Fabrizio | 2016-01-01 | POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ | - | 1.01 Articolo in rivista | - |
| Adverse Events to Food Supplements Containing Red Yeast Rice: Comparative Analysis of FAERS and CAERS Reporting Systems | Raschi, Emanuel*; Girardi, Anna; Poluzzi, Elisabetta; Forcesi, Emanuele; Menniti-Ippolito, France...sca; Mazzanti, Gabriela; De Ponti, Fabrizio | 2018-01-01 | DRUG SAFETY | - | 1.01 Articolo in rivista | - |
| Adverse events with sacubitril/valsartan in the real world: emerging signals to target preventive strategies from the FDA adverse event reporting system | Milo Gatti, Ippazio Cosimo Antonazzo, Igor Diemberger, Fabrizio De Ponti, Emanuel Raschi | 2021-01-01 | EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY | - | 1.01 Articolo in rivista | adverse effect.pdf; Adverse events with sacubitrilvalsartan in the real world.pdf |
| Adverse events with sodium-glucose co-transporter-2 inhibitors: A global analysis of international spontaneous reporting systems | Raschi, E.; Parisotto, M.; Forcesi, E.; La Placa, M.; Marchesini, G.; De Ponti, F.; Poluzzi, E. | 2017-01-01 | NMCD. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES | - | 1.01 Articolo in rivista | j.numecd.2017.10.008.pdf |
| Advising Mothers on the Use of Medications during Breastfeeding : A Need for a Positive Attitude | Davanzo, Riccardo; Bua, Jenny; De Cunto, Angela; Farina, Maria Luisa; De Ponti, Fabrizio; Clavenn...a, Antonio; Mandrella, Stefania; Sagone, Antonella; Clementi, Maurizio | 2016-01-01 | JOURNAL OF HUMAN LACTATION | - | 1.01 Articolo in rivista | - |
| Altered Serotonin Signaling and Extrinsic Sensory Neuron Activation in Irritable Bowel Syndrome | C. Cremon; G. Carini; G. Dothel; V. Vasina; R. De Giorgio; V. Stanghellini; F. De Ponti; M. Tonin...i; D. Grundy; R. Corinaldesi; G. Barbara | 2010-01-01 | GASTROENTEROLOGY | - | 4.02 Riassunto (Abstract) | - |
| Amyotrophic Lateral Sclerosis as an Adverse Drug Reaction: A Disproportionality Analysis of the Food and Drug Administration Adverse Event Reporting System | Gaimari A.; Fusaroli M.; Raschi E.; Baldin E.; Vignatelli L.; Nonino F.; De Ponti F.; Mandrioli J....; Poluzzi E. | 2022-01-01 | DRUG SAFETY | - | 1.01 Articolo in rivista | Amyotrophic.pdf |
| An update on the first decade of the European centralized procedure: how many innovative drugs? | Motola D.; De Ponti F.; Poluzzi E.; Martini N.; Rossi P.; Silvani M.C.; Vaccheri A.; Montanaro N. | 2006-01-01 | BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | - | 1.01 Articolo in rivista | - |
| Animal models of chemically induced intestinal inflammation: Predictivity and ethical issues | Giovanni Dothel; Valentina Vasina; Giovanni Barbara; Fabrizio De Ponti | 2013-01-01 | PHARMACOLOGY & THERAPEUTICS | - | 1.01 Articolo in rivista | - |
| Antibacterial macrolides: a drug class with a complex pharmacological profile | ABU-GHARBIEH E.; VASINA V.; POLUZZI E.; DE PONTI F. | 2004-01-01 | PHARMACOLOGICAL RESEARCH | - | 1.01 Articolo in rivista | - |